David Shaw’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$329M Sell
680,298
-839,263
-55% -$223M 0.16% 120
2026
Q1
$167M Sell
1,519,561
-932,819
-38% -$133M 0.1% 232
2025
Q4
$408M Sell
2,452,380
-94,756
-4% -$15.9M 0.22% 90
2025
Q3
$499M Buy
2,547,136
+516,739
+25% +$85M 0.28% 52
2025
Q2
$184M Sell
2,030,397
-1,345,848
-40% -$106M 0.13% 173
2025
Q1
$201M Buy
3,376,245
+929,384
+38% +$86M 0.18% 121
2024
Q4
$324M Buy
+2,446,861
New +$230M 0.24% 76

Other funds holding ALAB

David Shaw's ALAB Position: Q2 2026 in Review

David Shaw reduced its Astera Labs (ALAB) stake by 55% in Q2 2026, selling an estimated $223M and leaving 680,298 shares worth $329M. The position accounts for 0.16% of the portfolio, ranked #120.

David Shaw first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. The position peaked at $499M in Q3 2025. 984 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • David Shaw held 680,298 shares of Astera Labs worth $329M as of Q2 2026.
  • David Shaw sold 839,263 Astera Labs shares in Q2 2026, an estimated $223M.
  • Astera Labs made up 0.16% of David Shaw's portfolio in Q2 2026, its #120 holding.
  • David Shaw first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • David Shaw's Astera Labs position peaked at $499M in Q3 2025.
  • 984 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.